Literature DB >> 11329456

Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands.

F Vlaspolder1, P Singer, A Smit, R J Diepersloot.   

Abstract

A comparative evaluation of the Vidas system (bioMérieux, Marcy l'Etoile, France) and the Immulite System (Diagnostic Products Corporation) was performed using 500 prospectively collected serum samples. As part of a routine antenatal screening program, these samples were tested for hepatitis B surface antigen, and immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement between the two assay systems ranged from 98.0 to 99.8%. After discrepancy analysis the outcome in terms of relative sensitivity and specificity varied from 97.5 to 100%.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11329456      PMCID： PMC96099          DOI： 10.1128/CDLI.8.3.552-555.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  13 in total

1.  Surveillance of congenital rubella in Great Britain, 1971-96.

Authors:  P A Tookey; C S Peckham
Journal:  BMJ       Date:  1999-03-20

2.  The IMMULITE assay tube: a new approach to heterogeneous ligand assay.

Authors:  A L Babson; D R Olson; T Palmieri; A F Ross; D M Becker; P J Mulqueen
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

3.  Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems.

Authors:  W T Hofgärtner; S R Swanzy; R M Bacina; J Condon; M Gupta; P E Matlock; D L Bergeron; J J Plorde; T R Fritsche
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus.

Authors:  L Matter; M Gorgievski-Hrisoho; D Germann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

6.  Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.

Authors:  M Wilson; J S Remington; C Clavet; G Varney; C Press; D Ware
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Specificity of low anti-Toxoplasma IgG titers with IMx and AxSYM Toxo IgG assays.

Authors:  B Cimon; P Marty; O Morin; M H Bessières; C Marx-Chemla; F Gay-Andrieu; P Thulliez
Journal:  Diagn Microbiol Infect Dis       Date:  1998-09       Impact factor: 2.803

8.  Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG.

Authors:  M Lappalainen; P Koskela; M Koskiniemi; P Ammälä; V Hiilesmaa; K Teramo; K O Raivio; J S Remington; K Hedman
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

9.  The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.

Authors:  M Koskiniemi; M Lappalainen; P Koskela; K Hedman; P Ammälä; V Hiilesmaa; K Teramo
Journal:  Scand J Infect Dis Suppl       Date:  1992

10.  Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.

Authors:  P Hohlfeld; F Daffos; P Thulliez; C Aufrant; J Couvreur; J MacAleese; D Descombey; F Forestier
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406
View more
  11 in total

1.  A comparison of IgG anti-rubella activity in frozen serum stored in primary gel separation tubes or secondary tubes.

Authors:  V Ellis; A Charlett; R Bendall
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

2.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Can the common brain parasite, Toxoplasma gondii, influence human culture?

Authors:  Kevin D Lafferty
Journal:  Proc Biol Sci       Date:  2006-11-07       Impact factor: 5.349

4.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

5.  Evaluation of rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument.

Authors:  Maria Cristina Medici; Monica Martinelli; Valeria Albonetti; Carlo Chezzi; Giuseppe Dettori
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

6.  Performance characteristics of current-generation Immulite 2000 TORCH Assays.

Authors:  A R Centonze; E Tonolli; R Fontana
Journal:  Clin Vaccine Immunol       Date:  2012-11-21

7.  Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.

Authors:  Jean-Benjamin Murat; Coralie L'Ollivier; Hélène Fricker Hidalgo; Jacqueline Franck; Hervé Pelloux; Renaud Piarroux
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

8.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

9.  Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns.

Authors:  Jean-Benjamin Murat; Céline Dard; Hélène Fricker Hidalgo; Marie-Laure Dardé; Marie-Pierre Brenier-Pinchart; Hervé Pelloux
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

Review 10.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.